The Pathway to a Putative, Investigational Drug Candidate?

In the small molecule space it's a rare institution, even one as expansive as harvard, that has really all of the capabilities and expertise to take a mol le for proof of constant molecule through its pre clinical paste. There are places like end cats that have consolidated this expertise in many iandes to their name. These project focus, biotet companies are such a powerful catalyst for technology transition. You'll know, something that makes the inevitable happen faster.